Can cutaneous telangiectasiae as late normal-tissue injury predict cardiovascular disease in women receiving radiotherapy for breast cancer

British Journal of Cancer

Volumn 101, Issue 3, 2009, Pages 403-409

  Tanteles, G A ^a,b   Whitworth, J ^b   Mills, J ^b   Peat, I ^b   Osman, A ^b   McCann, G P ^c   Chan, S ^d   Barwell, J G ^a,b   Talbot, C J ^a   Symonds, R P ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c GLENFIELD HOSPITAL   (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Breast cancer; CVD; Late radiation damage; Telangiectasiae

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; RADIATION INJURY; TELANGIECTASIA; TISSUE INJURY;

AGED; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; RADIOTHERAPY; SKIN; SMOKING; TELANGIECTASIS;

EID: 68149125534     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605182     Document Type: Article

References (37)

1. Andreassen CN, Alsner J, Overgaard J, Herskind C, Haviland J, Owen R, Homewood J, Bliss J, Yarnold J (2005) TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol 75: 18-21
2. Archambeau JO, Pezner R, Wasserman T (1995) Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 31: 1171-1185
3. Belkacemi Y, Gligorov J, Ozsahin M, Marsiglia H, De Lafontan B, Laharie-Mineur H, Aimard L, Antoine EC, Cutuli B, Namer M, Azria D (2008) Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multi-centric study. Ann Oncol 19: 1110-1116
4. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR (2008) The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371: 1098-1107
5. Bentzen SM, Dorr W, Anscher MS, Denham JW, Hauer-Jensen M, Marks LB, Williams J (2003) Normal tissue effects: reporting and analysis. Semin Radiat Oncol 13: 189-202
6. Bonneterre J, Roche H, Kerbrat P, Fumoleau P, Goudier MJ, Fargeot P, Montcuquet P, Clavere P, Barats JC, Monnier A, Veyret C, Datchary J, Van Praagh I, Chapelle-Marcillac I (2004) Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group. J Clin Oncol 22: 3070-3079
7. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087-2106
8. Corn BW, Trock BJ, Goodman RL (1990) Irradiation-related ischemic heart disease. J Clin Oncol 8: 741-750
9. Darby S, McGale P, Peto R, Granath F, Hall P, Ekbom A (2003) Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women. BMJ 326: 256-257
10. Fiets WE, van Helvoirt RP, Nortier JW, van der Tweel I, Struikmans H (2003) Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. A prospective, comparative, non-randomised study. Eur J Cancer 39: 1081-1088
11. Gagliardi G, Lax I, Rutqvist LE (2001) Partial irradiation of the heart. Semin Radiat Oncol 11: 224-233
12. Giotopoulos G, Armstrong C, Osman A, Peat I, Symonds RP, Talbot CJ (2008) Refining the evidence for GSTA1 and eNOS genetic effects on risk of radiotherapy-induced telangiectasia. Int J Cancer 123: 2973-2974
13. Giotopoulos G, Symonds RP, Foweraker K, Griffin M, Peat I, Osman A, Plumb M (2007) The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer 96: 1001-1007
14. Gyenes G, Gagliardi G, Lax I, Fornander T, Rutqvist LE (1997) Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol 15: 1348-1353
15. Gyenes G, Rutqvist LE, Liedberg A, Fornander T (1998) Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 48: 185-190
16. Harris EE, Correa C, Hwang WT, Liao J, Litt HI, Ferrari VA, Solin LJ (2006) Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol 24: 4100-4106
17. Kuiper EJ, Van Nieuwenhoven FA, de Smet MD, van Meurs JC, Tanck MW, Oliver N, Klaassen I, Van Noorden CJ, Goldschmeding R, Schlingemann RO (2008) The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS ONE 3: e2675
18. Li JG, Williams SS, Goffinet DR, Boyer AL, Xing L (2000) Breast-conserving radiation therapy using combined electron and intensity-modulated radiotherapy technique. Radiother Oncol 56: 65-71
19. Marhin W, Wai E, Tyldesley S (2007) Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer. Int J Radiat Oncol Biol Phys 69: 483-489
20. Mouridsen H, Keshaviah A, Coates AS, Rabaglio M, Castiglione-Gertsch M, Sun Z, Thurlimann B, Mauriac L, Forbes JF, Paridaens R, Gelber RD, Colleoni M, Smith I, Price KN, Goldhirsch A (2007) Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial. J Clin Oncol 25: 5715-5722
21. Nilsson G, Holmberg L, Garmo H, Terent A, Blomqvist C (2009) Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke. Br J Cancer 100: 811-816
22. O'Sullivan B, Levin W (2003) Late radiation-related fibrosis: pathogenesis, manifestations, and current management. Semin Radiat Oncol 13: 274-289
23. Paszat LF, Mackillop WJ, Groome PA, Boyd C, Schulze K, Holowaty E (1998) Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 16: 2625-2631
24. Paszat LF, Mackillop WJ, Groome PA, Schulze K, Holowaty E (1999) Mortality from myocardial infarction following postlumpectomy radio-therapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 43: 755-762
25. Paszat LF, Vallis KA, Benk VM, Groome PA, Mackillop WJ, Wielgosz A (2007) A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer. Radiother Oncol 82: 294-300
26. Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, Gonzales-Gonzales D, Horiot JC, Bolla M, Bartelink H (1995) EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 35: 11-15
27. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K (2003) Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 160: 381-407
28. Quarmby S, Fakhoury H, Levine E, Barber J, Wylie J, Hajeer AH, West C, Stewart A, Magee B, Kumar S (2003) Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol 79: 137-143
29. Requena L, Sangueza OP (1997) Cutaneous vascular anomalies. Part I. Hamartomas, malformations, and dilation of preexisting vessels. JAm Acad Dermatol 37: 523-549.
30. Rutqvist LE, Johansson H (1990) Mortality by laterality of the primary tumour among 55 000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer 61: 866-868
31. Seddon B, Cook A, Gothard L, Salmon E, Latus K, Underwood SR, Yarnold J (2002) Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy. Radiother Oncol 64: 53-63
32. Shaffer R, Tyldesley S, Rolles M, Chia S, Mohamed I (2009) Acute cardiotoxicity with concurrent trastuzumab and radiotherapy including internal mammary chain nodes: a retrospective single-institution study. Radiother Oncol 90: 122-126
33. Stewart JR, Fajardo LF, Gillette SM, Constine LS (1995) Radiation injury to the heart. Int J Radiat Oncol Biol Phys 31: 1205-1211
34. Taylor CW, Povall JM, McGale P, Nisbet A, Dodwell D, Smith JT, Darby SC (2008) Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys 72: 501-507
35. Trott KR (1984) Chronic damage after radiation therapy: challenge to radiation biology. Int J Radiat Oncol Biol Phys 10: 907-913
36. van den Belt-Dusebout AW, Nuver J, de Wit R, Gietema JA, ten Bokkel Huinink WW, Rodrigus PT, Schimmel EC, Aleman BM, van Leeuwen FE (2006) Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 24: 467-475
37. van der Kogel AJ (1993) Radiobiology of normal tissues. In Basic Clinical Radiobiology Steel GG (ed). pp 99-107. London: Arnold